At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Holmium laser enucleation of prostate +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Holmium Laser Enucleation of the Prostate Versus Monopolar Transurethral Resection of the Prostate in Management of Benign Prostatic Hyperplasia.
In Brief
A clinical study evaluating Holmium laser enucleation of prostate and monopolar transurethral resection of prostate for Prostatic Hyperplasia. Completed, enrolled 60 participants across 1 site.
Detailed Summary
To compare the clinical outcome regarding safety and efficacy between Holmium laser enucleation of the prostate and transurethral resection of the prostate in management of benign prostatic hyperplasia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatic Hyperplasia
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
Primary CompletionFeb 2020
Study CompletionFeb 2020
First PostedSep 2020
TodayJul 2026
First PostedSep 23, 2020
Enrollment StartFeb 1, 2018
Primary CompletionFeb 1, 2020
Study CompletionFeb 29, 2020
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 5.8 years ago
Interventions
Holmium laser enucleation of prostateprocedure
surgical management of BPH by Holmium laser enucleation using 0.9% saline fluid for irrigation
monopolar transurethral resection of prostateprocedure
surgical management of BPH by monopolar TURP using distilled water for irrigation